MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Cuts Stock Holdings in Danaher Co. (NYSE:DHR)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH reduced its position in Danaher Co. (NYSE:DHR) by 33.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 661 shares of the conglomerate’s stock after selling 330 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in Danaher were worth $165,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of DHR. Cape Investment Advisory Inc. purchased a new position in shares of Danaher during the 4th quarter worth $25,000. Tsfg LLC increased its stake in Danaher by 733.3% during the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 88 shares during the last quarter. BKM Wealth Management LLC acquired a new position in shares of Danaher in the 4th quarter valued at $27,000. Wetzel Investment Advisors Inc. purchased a new stake in Danaher in the 4th quarter valued at about $29,000. Finally, Rakuten Securities Inc. acquired a new position in Danaher in the fourth quarter valued at about $36,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on DHR. HSBC raised shares of Danaher from a “hold” rating to a “buy” rating and boosted their price target for the company from $250.00 to $280.00 in a research note on Wednesday, April 17th. Bank of America increased their target price on Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 24th. Barclays lifted their target price on Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 24th. TD Cowen raised their price objective on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Finally, StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, June 25th. Six equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $268.67.

Insiders Place Their Bets

In related news, CEO Rainer Blair sold 9,005 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the sale, the chief executive officer now owns 106,990 shares of the company’s stock, valued at $28,352,350. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, CEO Rainer Blair sold 9,005 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the sale, the chief executive officer now owns 106,990 shares in the company, valued at $28,352,350. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Matthew Mcgrew sold 46,377 shares of the business’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $253.05, for a total value of $11,735,699.85. Following the completion of the transaction, the chief financial officer now owns 29,407 shares of the company’s stock, valued at $7,441,441.35. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 148,783 shares of company stock valued at $37,536,717. Corporate insiders own 10.90% of the company’s stock.

Danaher Stock Down 1.7 %

DHR opened at $240.41 on Wednesday. Danaher Co. has a one year low of $182.09 and a one year high of $269.11. The company has a market cap of $178.07 billion, a price-to-earnings ratio of 40.75, a PEG ratio of 3.82 and a beta of 0.84. The business’s fifty day moving average is $256.13 and its two-hundred day moving average is $246.86. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. During the same period in the prior year, the company earned $2.36 EPS. The firm’s revenue was down 2.6% on a year-over-year basis. Analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date is Friday, June 28th. Danaher’s dividend payout ratio (DPR) is presently 18.31%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.